afatinib plus cetuximab in resistant non-small cell lung cancer
Published 9 years ago • 1.2K plays • Length 8:38Download video MP4
Download video MP3
Similar videos
-
1:30
dr. langer on afatinib for advanced non-small cell lung cancer
-
1:35
dr. janjigian discusses afatinib and cetuximab for patients with egfr-mutant lung cancer
-
0:51
dr. west discusses afatinib and cetuximab combination in nsclc
-
0:58
the activity of afatinib in lung cancer
-
4:29
non–small cell lung cancer: other actionable mutations
-
1:25
dr. chachoua on afatinib for exon 19 mutation in lung cancer
-
4:47
treating non–small cell lung cancer with an egfr exon 20 insertion
-
5:54
frontline alk, egfr inhibition in non-small cell lung cancer
-
7:44
next-generation targeted therapies in non-small cell lung cancer
-
1:59
dr. tolba on the use of afatinib in nrg1-mutated lung adenocarcinoma
-
6:57
egfr exon 20 mutations in non–small cell lung cancer
-
6:23
adaura trial; early stage non–small cell lung cancer
-
4:38
molecular testing’s role in non–small cell lung cancer
-
1:25
dr. bunn discusses afatinib in lung cancer
-
3:07
targeting angiogenesis in non–small cell lung cancer
-
4:52
targeting the immune system in non-small cell lung cancer
-
8:16
immune checkpoint inhibitor combinations in non-small cell lung cancer
-
5:50
targeted therapy in egfr exon 20-mutant non–small cell lung cancer
-
6:43
molecular testing in patients with metastatic nsclc